This paper presents the development in Victoria of a medical specialty that was new to Australia. Similar developments were occurring in other states and New Zealand, with Sydney an early leader. Nuclear medicine was already well established in the United States but less so elsewhere except for some units in the United Kingdom and Europe. The interest of medicine in the new fi eld arose from the ease with which physiological measurements could be made with radioisotopes, and to the fact that images could be made with non-invasive techniques. Some lesions could also be localised more easily and targeted with radioisotopes, if necessary.
Nuclear medicine uses radiations emitted from radionuclides administered as unsealed sources to assess function, to image specifi c organs, and to treat certain diseases. Procedures include routine clinical diagnosis and treatment, as well as research techniques. The nuclear medicine department thus undertakes the major clinical uses of radionuclides, with medical, nursing, technical, and scientifi c staff.
An important principle is the use of as little radionuclide (the minimum amount of radiation) as is necessary to obtain the maximum amount of information. In contrast, therapeutic doses direct a high dose of radiation from a source to the lesion. In either case, the dose is related to the type and energy of the emission and the half-life of the radionuclide.
Sealed radioisotopes had been used in treatment for many years before nuclear medicine developed as a specialty, for example: radium isotopes sealed in needles, plaques or seeds in carcinoma of the cervix. This contrasts with unsealed sources given orally, intravenously or by inhalation in nuclear medicine, which was fi rst used in the 1930s.
The Beginnings
The discovery of 131Iodine (131I) and 32Phosphorus (32P) in the late 1930s was important in the development of radioisotopes in medicine but World War II delayed their introduction and availability until late in the 1940s. An exception was the use of 32P supplied by an American scientist from the US Army in 1944 for nineteen patients in Queensland. During the 1940s 131I and 32P were used in diagnosis and treatment. The Geiger counter was the main monitor. Radioisotopes became generally available in the 1950s and advances occurred with the introduction of scintillation detectors, the tagging with radionuclides (60Cobalt-labeled vitamin B12), labeled red cells in blood disorders, and manual organ scanning techniques introduced in Australian hospitals to localise lesions. Further major imaging advances were developed in the United States; Veall and Vetter wrote in 1958: 'the progress in radioactive instrumentation is so rapid nowadays that one can always feel sure that something a little better is going to be available in a few months' time. ' 1 This has been borne out by the steady advances in instrumentation and radiopharmaceuticals such as: the fi rst automatic rectilinear scanner (B. Cassen, University of California, 1951), the fi rst gamma camera (A. Anger, University of California, Berkeley, 1964) , and the introduction of 99mTechnetium (99mTc) into clinical practice (Harper, 1964) . The adoption of these advances led to nuclear medicine becoming established as a medical specialty.
The Early Period in Victoria
Far-sighted clinicians used radioisotopes for many years before nuclear medicine became a distinct discipline. Radiotherapists treated thyroid cancer and polycythaemia, endocrinologists diagnosed and treated thyrotoxicosis, haematologists performed red blood cell studies, and medical and biological research workers used the new techniques. Work was done at major hospitals and also the Baker Institute.
At for the distribution of radionuclides. The Council for Scientifi c and Industrial Research (CSIR) was also involved until 1951, but CXRL then became the sole authority for producing and distributing nuclides until 1961. 4 From 1948, the CXRL provided physics expertise with the ground work by T. H. Oddie. It acted as a consultant with practical assistance and equipment for the RMH, the University of Melbourne, St. Vincent's Hospital and the Baker Institute. 5 In 1958 the new reactor HIFAR started at Lucas Heights, NSW, and the AAEC became part of the development of nuclear medicine. In 1966 the PMC used 99mTechnetium (99mTc) for the fi rst time. 6 CXRL started a daily delivery of 99mTc in Melbourne, and scanning further increased. D. Stevens, director of CXRL, and his assistant D. Keam played major roles, and the latter became increasingly involved, becoming an offi ce bearer, and later president, of the ANZSNM.
From 1968 R. Boyd (a radiopharmacist and later president of ANZSNM) and his team at the AAEC began producing 99mTc radiopharmaceuticals that were available nationally and were 
Nuclear Medicine as a Medical Specialty
With the introduction of radioisotope imaging the medical use of radionuclides grew steadily despite some interruptions. The major advances followed the development of new radiopharmaceuticals with special physical and chemical properties, new imaging equipment and the introduction of computers. Imaging has therefore been a key factor in the development of the specialty, and the technical advances have refl ected those occurring in other imaging areas: x-ray computed tomography, ultrasound and magnetic resonance imaging (MRI).
The demand for NM work fell when radionuclide brain and liver-spleen scans were replaced in some cases by x-ray computed tomography (CT). The fi rst CT scanner was introduced at RMH in 1975. Other studies such as placentography were replaced by ultrasound. This fall was offset by newer NM investigations, especially cardiac and tumour localisation techniques, and the diagnostic area expanded constantly with NM techniques complementing rather than competing with radiology and ultrasound. Examples are chest x-ray and lung scans in pulmonary embolism, with ultrasound studies in deep venous thrombosis. The best combination can be selected for the problem, and NM is valuable with its non-invasive techniques and often lower radiation dose. NM has the unique features of being non-invasive and functional in nature: 'The basis of uptake of the [radionuclide] tracer in a system or organ of interest is the physiological response of the body to the molecule containing the radioactive atom.' 8 Imaging was of course not the only activity of the NM department but it was the one in which rapid changes occurred. Other tasks included 51Chromium studies in bowel cancer screening, the 14Carbon urea breath test for Helicobacter Pylori in peptic ulceration and 131Iodine treatment for thyrotoxicosis and thyroid cancer. Therapeutic developments increased but played a lesser role in NM than imaging. In addition research was undertaken early and has continued in many areas, supported by grants such as those from the National Health and Medical Research Council and universities.
Nuclear Medicine Departments and Staff
The development of NM followed the establishment of dedicated departments headed by medical specialists who were supported by technical and scientifi c staff, similar to the United States. Some centres in New Zealand and the United Kingdom differed in that physicists were leaders. Some departments were allied with radiology, but most, like those at the Royal Melbourne and Royal Prince Alfred Hospitals, were autonomous. The fi rst integrated department was at the RMH under J. T. Andrews, a medical graduate from the UK who trained at PMC. The Alfred Hospital (AH) followed, with J. M. Dugdale 12 But other branches of medicine were also interested, and in 1967 the Royal Australasian College of Physicians (RACP), the College of Pathologists and representatives from Melbourne and Sydney Universities opposed the formation of a diploma in NM to be granted by the RACR alone. In 1968 they proposed a joint diploma from the RACP and RACR, but this did not proceed. Both RACP and RACR were very supportive of NM, and J. T. Andrews (who was a fellow of both colleges) received a study grant in 1968 from the RACP to attend a course at the AAEC in Lucas Heights, and in 1989 a Baker Fellowship from the RACR to study overseas. Hence the colleges were individually supportive of the emerging specialty, but it was some years before a combined approach developed. A feature of the fi rst meeting was a debate about which college the society should affi liate with for training of NM specialists. A minority favoured radiology, but the majority (mainly NSW) were involved in internal medicine and preferred the RACP. Failing support for a combined diploma, NM training thus became a sub-specialty of internal medicine.
Training of Medical Personnel
The decision reached above led to NM becoming a subspecialty of the RACP, together with fi elds such as cardiology and neurology. It was examined in part II of the college certifi cate of fellowship. There were some political implications of this alliance, as there were continuing pressures for NM to become nuclear radiology. The RANZCR history records, 'the College considered that it should be integrated with radiology.' 13 Ultimately a joint Specialist Advisory Committee in NM was established by the RACP and RANZCR to supervise and assess training for both physicians and radiologists.
Formal training and qualifi cation in NM in Australasia was an international fi rst, though some early NM practitioners also qualifi ed for the certifi cate of the new American Board of Nuclear Medicine which was initiated in 1972. Although most NM specialists trained locally, some in Australia and New Zealand trained overseas in the United States or United Kingdom. An important early arrival was I. P. C. Murray from the United Kingdom, who led the NM unit at Prince of Wales Hospital, NSW. He was later president of the World Federation of NM and Biology, was awarded the medal of Member in the Order of Australia for his work, and was co-editor of a major international two-volume text on NM. 14 
Australian and New Zealand Association of Physicians in Nuclear Medicine (ANZAPNM)
This body was formed in 1970. It was founded by NM specialists who regularly gathered together, and they launched the association at a restaurant (the Hungry Horse) in Paddington in Sydney. 15 It became very sophisticated, concerned with all aspects of the practice of physicians in NM. Its members, numbering over two hundred, are NM practitioners qualifi ed mainly by the RACP or RANZCR. It is an active association, and L. B. Arkles from Victoria was president from 1978 to 1980. Australia has been generally well served in NM, but New Zealand less so, leading to a shortage of training positions in the latter.
Training of Technologists K. Clarke and J. Milne at PMC conducted training of qualifi ed radiographers in radioisotope techniques, with additional subjects provided by the Royal Melbourne Institute of Technology (RMIT). As the use of radioisotopes increased the need for specifi cally trained technologists led to the preparation of a separate course from that for the therapy radiographer, and in 1964 a three year course in parallel with the two existing radiography courses commenced at RMIT, leading to the fi rst qualifi cation in nuclear medicine technology. The course was expanded to a full three year Diploma in Nuclear Medicine Technology in 1973, the fi rst of its kind in the world, and then to the degree of Bachelor of Applied Science in Medical Radiations (NM). This is now the standard for university programs for NM technology. RMIT also provided a correspondence diploma course for non-Victorian technologists until the conversion to the degree course occurred. RMIT University thus played a key role in training NM technologists. 18 Fourteen graduated in 2006 and eighteen in 2007, and the program has expanded to provide honours, masters and a doctorate. Victoria is fortunate that the state government funds internships for the graduates. The total number in the radiodiagnostic, radiotherapy, ultrasound and NM courses is regularly about one hundred annually. Graduates are keenly sought both in Australia and New Zealand. States other than Victoria also followed RMIT's example, leading to a national provision of NM technology.
ANZSNM Aims and Objectives
These are to promote clinical practice, public education, cooperation with other organisations and training of persons in all facets of NM. There are three standing committees: the accreditation board, the technical standards committee and the research grant committee.
The ANZ Nuclear Medicine Journal is published quarterly. Special credit is due to G. Lowenthal of the AAEC who served as editor for several years. Regular scientifi c meetings are held in various regions, and an annual scientifi c meeting in different cities on a rotating basis.
The Accreditation Board was established in 1975 to defi ne a standard of excellence and ensuing accreditation for NM technologists, ensuring their competence in both in-vivo and in-vitro procedures using unsealed radioactive sources. 19 The board's role has further expanded to accreditation of courses and applicants from overseas, and approval of hospital departments for training. It has also provided a special examination for those precluded by distance from attending a standard course, and in this way has assisted would-be NM technologists to obtain accreditation from Australia, New Zealand and elsewhere.
Special interest groups include technologists, physicists, radiopharmacists and nurses. The Society of Nuclear Medicine Technologists is the largest and is very active. The parent society has been strengthened greatly by the contributions of these groups.
Radiation Advisory Committee (RAC)
This was established in Victoria in 1984 under the Health Act 1958. Prior to this the Consultative Council on Radiation Safety had issued licenses in areas such as haematology and endocrinology.
The RAC responsibilities included:
the promotion of radiation safety procedures and • practices recommending the criteria for the licensing of persons • and the qualifi cations, training and experience required for licensing recommending the criteria for the registration of • radiation apparatus and sealed radiation sources recommending the nature, extent and frequency of • periodic safety assessments of radiation apparatus and sealed radioactive sources codes of practice with respect to particular radioactive • substances and uses of ionizing and non-ionizing radiation any matter which the minister agrees the committee • should consider and report on.
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The RAC was also active in discussions on NM in Victoria. Prior to 1993 W. S. C. Hare was chairman and J. T. Andrews from NM at RMH was a member. The committee reviewed the specialist recognition in NM granted by the National Specialist Qualifi cation Advisory Committee and instigated the license to practice NM (with a grandfather clause for selected individuals of long standing in NM). Hence the RAC was infl uential in NM in Victoria. The Medical Radiation Technologists Registration Board was also established.
Changing Techniques
Gamma cameras became available in the late 1960s, enabling dynamic as well as static imaging to be done. Automatic scanners were thus being displaced, and computers were also introduced. NM studies rapidly increased until the advent of x-ray computed tomography (CT scan) and ultrasound. However in the 1970s and 1980s single photon emission computed tomography (SPECT) brought tomography into NM practice and reintroduced the brain scan in a different functional format. The evaluation of cardiac function with the cardiac gated blood pool scanning and the myocardial stress test with SPECT became the next major demand for NM studies, with technetium-analogues in place of the earlier thallium studies. The demand for these studies has led to a special gamma camera design. Other advancing areas have been the localisation of tumours using monoclonal antibodies and localising infection with labeled white blood cells. 21 The next development was combining CT with SPECT in one machine, the present state of the art. In the 1990s the experimentally established positron emission tomography (PET) became clinically available. It requires a complex ring of detectors and a cyclotron to produce the positron emitting radioisotope by 511 kev annihilation.
Great interest in the use of cyclotrons for the production of radioisotopes goes as far back as the efforts of J. McCrae at the University of Sydney and others in the 1960s, but clinical adoption occurred very slowly. The Australian Government decided in 1996 to establish a national cyclotron in Royal Prince Alfred Hospital (RPA), Sydney, operated by the Australian Nuclear Science and Technology Association (ANSTO, previously AAEC) and the hospital. The RPA had played a leading role in NM, and the PET centre there was opened by the Governor General Bill Hayden in March 1992. 22 The clinical use of the cyclotron was a signifi cant advance for ANSTO in radionuclide production, a task it shared with the Lucas Heights reactor. However, 'for the vast majority of radioisotopes, including all those used medically, the cyclotron complements the reactor-it does not replace it.' 23 Considerable interest in recent years has been expressed in the use of the cyclotron to produce 99mTc, which is used in over 80 percent of NM studies, instead of production in the reactor. 24 The new reactor which replaced the aging HIFAR machine at Lucas Heights, NSW, intensifi ed this interest. It is however still standard NM practice to obtain 99mTc from a longer half-life 99Mo generator (t1/2 66 hours as opposed to 6 hours for 99mTc) currently produced in a reactor and, in general, delivered weekly to NM departments. This requires local production or importation, with ensuing problems of radioactive waste and ultimate decommissioning of the reactors. In contrast, with the cyclotron technique minimal radioactive waste occurs. At the time of writing cyclotron production is still not available commercially, and NM departments still have to produce their 99mTc from 99Mo generators.
The Austin Hospital, Melbourne, PET centre opened in 1992, with an associated cyclotron and radiochemistry laboratory.
67Gallium for tumour localisation and 201Thallium for cardiac studies became available and cyclotrons producing further radionuclides such as 11Carbon, 15Oxygen and 18Fluorine for PET studies, but many have short half-lives, making their use impractical at a distance. Victoria is fortunate to have accessible cyclotron facilities for the PET centres, particularly at the Austin and Repatriation Medical Centre with C. Rowe and A. Scott supported by scientists and technicians, and PMC with R. Hicks supported by D. Binns and others. Government support for PET is well established in Australia.
The PET camera gives high resolution. Radionuclides enable it to detect metabolic changes in brain and heart, and to localise lesions. Its importance continually increases in oncology, neurology and cardiology. With combined use of PET and CT, as with SPECT and CT, NM and radiological imaging are drawn closer together.
Conclusion
The ANZ Society of Nuclear Medicine, begun by a handful of enthusiasts, has over 1,000 members, with over 300 in Victoria and nearly 400 in NSW at the time of writing. In 1994 its silver jubilee was held in Brisbane, and the Sixth World Congress of the World Federation of Nuclear Medicine and Biology was held in Sydney-a signifi cant double event. NM has been a major advance in clinical and laboratory medicine, and this paper presents features of its formative years and its emergence as a specialty in Victoria up to the 1990s. A further paper would be necessary to present current details of NM in both public and private medical practice, and the details of medical, scientifi c and other staff involved. Briefl y, in Australia there are now more than two hundred licensed NM departments, with one third in Victoria. New Zealand with a population similar to Victoria (about four million) has fewer departments. 
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